A subset of these preneoplastic lesions including benign nevi, lung adenomas, and prostatic intra-epithelial neoplasia eventually override this safeguard mechanism through the loss of p53, RB, INK4a and ARF and progress to malignant tumors5–8. The gene discussed is CDKN2A; the disease is lung adenoma.